Valuation: Genesis Fertility Center

Market Cap 475M 14.4M 12.46M 11.65M 10.65M 20.06M 1.37B 20.37M 137M 53.6M 687M 54.05M 52.87M 2.29B P/E 2026 *
30.9x
P/E 2027 * 27x
Enterprise Value 475M 14.4M 12.46M 11.65M 10.65M 20.06M 1.37B 20.37M 137M 53.6M 687M 54.05M 52.87M 2.29B EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.29x
Free-Float
17.02%
Yield 2026 *
2.31%
Yield 2027 * 2.31%
05-14 Genesis Fertility Center Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-14 Genesis Fertility Center Public Company Limited Announces Board and Committee Changes CI
02-23 Genesis Fertility Center Public Company Limited Proposes Cash Dividend for the Year Ended 31 December 2025, Payable on 26 May 2026 CI
02-23 Genesis Fertility Center Public Company Limited Announces Changes in Committee Compositions, Effective February 23, 2026 CI
02-23 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
12-17 Genesis Fertility Center Public Company Limited Announces Board and Committee Resignations, Effective December 16, 2025 CI
11-10 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-09-16 Genesis Fertility Center appoints Nathee Tungchitsodsai as CEO RE
25-09-15 Genesis Fertility Center Public Company Limited Announces Appointment of Nathee Tungchitsodsai as Chief Executive Officer, Effective 16 October 2025 CI
25-09-12 90,750,000 Common Shares of Genesis Fertility Center Public Company Limited are subject to a Lock-Up Agreement Ending on 13-SEP-2025. CI
25-08-15 Genesis Fertility Center Public Company Limited Announces Executive Changes CI
25-08-13 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-12 Genesis Fertility Center Public Company Limited Announces Cash Dividend for the Period from January 1, 2025 to June 30, 2025, Payable on September 10, 2025 CI
Manager TitleAgeSince
Chief Executive Officer - 2025-10-15
Director of Finance/CFO 48 2019-12-31
Chief Operating Officer 43 2016-12-07
Director TitleAgeSince
Chairman 57 2016-12-07
Director/Board Member 53 2021-11-15
Director/Board Member 57 2016-12-07
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 14.55M
-0.63%-9.93%+46.29%+28.33% 122B
-0.21%+1.14%+7.40%+53.42% 89.49B
-0.32%+4.78%+7.10%+57.10% 30.64B
-0.27%+2.10%+32.78%+76.58% 26.31B
+0.13%-0.81%-11.89%-13.98% 21.65B
-0.51%+4.34%+56.54%+253.11% 21.11B
+0.62%-5.68%+2.05%-11.73% 12.88B
-0.31%-22.16%+40.96%+67.76% 11.72B
-0.28%-2.60%-14.02%+94.63% 10.97B
Average -0.41%-2.99%+18.58%+67.25% 38.57B
Weighted average by Cap. -0.60%-2.53%+25.05%+53.96%

Financials

2026 *2027 *
Net sales 346M 10.48M 9.07M 8.48M 7.75M 14.61M 1B 14.84M 99.45M 39.03M 500M 39.36M 38.5M 1.67B 368M 11.15M 9.65M 9.02M 8.24M 15.54M 1.06B 15.78M 106M 41.51M 532M 41.86M 40.95M 1.77B
Net income 15M 454K 393K 368K 336K 633K 43.34M 643K 4.31M 1.69M 21.68M 1.71M 1.67M 72.21M 17M 515K 446K 417K 381K 718K 49.12M 729K 4.89M 1.92M 24.57M 1.93M 1.89M 81.84M
Net Debt - -
Logo Genesis Fertility Center
Genesis Fertility Center PCL is a Thailand-based company engaged in the healthcare sector, primarily providing fertility and reproductive healthcare services. The Company provides treatment and counseling services to infertile people, chromosome analysis by NGS technique services and provide investment services in other businesses, consulting and management services. The Company provides assisted reproductive technology services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI) and Intrauterine Insemination (IUI). Its service offerings also include Frozen Embryo Transfer (FET), egg freezing services and Preimplantation Genetic Testing for Aneuploidy (PGT-A) using laboratory-based screening methods. The Company serves both domestic and international patients through its network of fertility clinics and healthcare facilities. The Company operates through its subsidiaries such as Genosomics Company Limited, GFC Fertility Group Company Limited, and others.
Employees
-